Close Menu

NEW YORK — Early cancer detection firm Grail said last week that it will introduce its Galleri blood-based multi-cancer screening test in the UK next year through a partnership with the country's National Health Service (NHS).

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.